PALOVIA SKIN RENEWING LASER: THE AT-HOME LASER PERFECT FOR POST-SURGICAL PATIENTS

With the over-saturation of at-home laser treatments, it’s easy to become discouraged not knowing if the results promised are true or not. With the breakthrough at-home laser, PaloVia, it promises to provide optimal results and more.

In the past, achieving any type of skin renewal result or fine line reduction was only obtainable at a doctor’s office. Now, these same results can be achieved through Palomar’s recent release of their PaloVia system - the only FDA-cleared at-home laser clinically proven to reduce fine lines and wrinkles around the eyes.

How PaloVia Works

The PaloVia Skin Renewing Laser works below the surface – where lotions and creams don’t reach – to treat where wrinkles form. Short pulses of micro-fine laser light reach deeply into the skin’s sub-layers, treating the aging support structure. Then the body’s natural healing process sweeps away older, damaged tissue and rebuilds it with fresh, new collagen and elastin.

In clinical studies, patients who used the PaloVia just three to four minutes per day for one month showed dramatic results in the reduction of eye wrinkles.

PaloVia for Post-Operative Facelifts, Breast & Abdomen Surgery

We often encourage our post-operative facelift patients to use the PaloVia for quicker healing of scars as well as treatment of residual fine lines. Scars of the face, breasts and abdomen heal quicker with the use of daily treatments with this device. And the best of all, the PaloVia is very easy to use and only requires a few minutes of your time per day. An off label use recently discovered by Dr. Lewis Obi was the relief of muscle pain resulting from a karate injury.

Watch the following video for a demonstration of the PaloVia handheld skin renewal laser to how easy it is to operate at-home.

If you would like to purchase your very own PaloVia and to learn more information, we encourage you to contact our Renaissance, Center for Cosmetic Renewal and discover all the benefits of PaloVia.